Xing‐Jie Liang

42.6k total citations · 16 hit papers
472 papers, 33.3k citations indexed

About

Xing‐Jie Liang is a scholar working on Biomedical Engineering, Molecular Biology and Biomaterials. According to data from OpenAlex, Xing‐Jie Liang has authored 472 papers receiving a total of 33.3k indexed citations (citations by other indexed papers that have themselves been cited), including 228 papers in Biomedical Engineering, 204 papers in Molecular Biology and 154 papers in Biomaterials. Recurrent topics in Xing‐Jie Liang's work include Nanoplatforms for cancer theranostics (164 papers), Nanoparticle-Based Drug Delivery (138 papers) and RNA Interference and Gene Delivery (97 papers). Xing‐Jie Liang is often cited by papers focused on Nanoplatforms for cancer theranostics (164 papers), Nanoparticle-Based Drug Delivery (138 papers) and RNA Interference and Gene Delivery (97 papers). Xing‐Jie Liang collaborates with scholars based in China, United States and Germany. Xing‐Jie Liang's co-authors include Shubin Jin, Jinchao Zhang, Paul Wang, Juan Liu, Shuaidong Huo, Yuliang Zhao, Weisheng Guo, Yuanyu Huang, Xiaowei Ma and Xu Zhang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Advanced Materials.

In The Last Decade

Xing‐Jie Liang

458 papers receiving 33.0k citations

Hit Papers

pH-Sensitive nano-systems... 2011 2026 2016 2021 2013 2012 2012 2019 2011 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. pH-Sensitive nano-systems for drug delivery in cancer therapy
    2013 891 citations Juan Liu, Shubin Jin et al. profile →
  2. Size-Dependent Localization and Penetration of Ultrasmall Gold Nanoparticles in Cancer Cells, Multicellular Spheroids, and Tumors in Vivo
    2012 743 citations Keyang Huang, Huili Ma et al. ACS Nano profile →
  3. DNA Origami as a Carrier for Circumvention of Drug Resistance
    2012 619 citations Xing‐Jie Liang et al. profile →
  4. Carbon-dot-supported atomically dispersed gold as a mitochondrial oxidative stress amplifier for cancer treatment
    2019 544 citations Ningqiang Gong, Shuaidong Huo et al. profile →
  5. Gold Nanoparticles Induce Autophagosome Accumulation through Size-Dependent Nanoparticle Uptake and Lysosome Impairment
    2011 521 citations Shubin Jin, Xing‐Jie Liang et al. ACS Nano profile →
  6. Comprehensive understanding of magnetic hyperthermia for improving antitumor therapeutic efficacy
    2020 510 citations Xiaoli Liu, Haiming Fan et al. profile →
  7. Size-dependent radiosensitization of PEG-coated gold nanoparticles for cancer radiation therapy
    2012 430 citations Xing‐Jie Liang et al. Biomaterials profile →
  8. Natural Berberine-Based Chinese Herb Medicine Assembled Nanostructures with Modified Antibacterial Application
    2019 342 citations Xing‐Jie Liang et al. ACS Nano profile →
  9. The challenge and prospect of mRNA therapeutics landscape
    2020 310 citations Yuhua Weng, Tongren Yang et al. profile →
  10. Thermo-responsive triple-function nanotransporter for efficient chemo-photothermal therapy of multidrug-resistant bacterial infection
    2019 268 citations Guangchao Qing, Ningqiang Gong et al. profile →
  11. Temperature-Sensitive Lipid-Coated Carbon Nanotubes for Synergistic Photothermal Therapy and Gene Therapy
    2021 213 citations Shutao Guo, Xing‐Jie Liang et al. ACS Nano profile →
  12. BODIPY as a Multifunctional Theranostic Reagent in Biomedicine: Self‐Assembly, Properties, and Applications
    2022 173 citations Xing‐Jie Liang et al. Advanced Materials profile →
  13. Blood-brain barrier–penetrating single CRISPR-Cas9 nanocapsules for effective and safe glioblastoma gene therapy
    2022 156 citations Xing‐Jie Liang et al. Science Advances profile →
  14. Brain Co‐Delivery of Temozolomide and Cisplatin for Combinatorial Glioblastoma Chemotherapy
    2022 146 citations Xing‐Jie Liang et al. Advanced Materials profile →
  15. Lipid Nanoparticles Optimized for Targeting and Release of Nucleic Acid
    2023 86 citations Jinchao Zhang, Xing‐Jie Liang et al. Advanced Materials profile →
  16. Blood–Brain Barrier‐Penetrating and Lesion‐Targeting Nanoplatforms Inspired by the Pathophysiological Features for Synergistic Ischemic Stroke Therapy
    2024 61 citations Xing‐Jie Liang et al. Advanced Materials profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xing‐Jie Liang China 99 15.7k 12.7k 10.3k 10.0k 2.5k 472 33.3k
Gang Liu China 98 17.5k 1.1× 10.9k 0.9× 11.8k 1.1× 7.7k 0.8× 1.7k 0.7× 962 37.8k
Yaping Li China 93 14.6k 0.9× 10.5k 0.8× 6.9k 0.7× 10.9k 1.1× 3.3k 1.3× 817 33.5k
Weibo Cai United States 93 15.8k 1.0× 9.8k 0.8× 11.0k 1.1× 7.5k 0.7× 3.8k 1.5× 452 33.7k
Samir Mitragotri United States 107 16.6k 1.1× 13.9k 1.1× 7.3k 0.7× 13.5k 1.4× 1.9k 0.8× 357 48.6k
Ick Chan Kwon South Korea 100 13.8k 0.9× 12.7k 1.0× 5.5k 0.5× 15.0k 1.5× 1.9k 0.8× 452 33.9k
Kwangmeyung Kim South Korea 88 12.1k 0.8× 10.0k 0.8× 4.8k 0.5× 11.2k 1.1× 2.0k 0.8× 381 25.8k
Morteza Mahmoudi United States 89 14.4k 0.9× 9.0k 0.7× 10.7k 1.0× 13.3k 1.3× 1.1k 0.4× 336 32.7k
Xian‐Zheng Zhang China 114 26.3k 1.7× 13.6k 1.1× 12.9k 1.3× 16.3k 1.6× 2.1k 0.9× 774 47.1k
Xiangliang Yang China 85 11.4k 0.7× 7.2k 0.6× 6.5k 0.6× 6.4k 0.6× 1.5k 0.6× 510 25.5k
Wei Tao China 91 12.9k 0.8× 9.3k 0.7× 7.8k 0.8× 7.1k 0.7× 1.6k 0.6× 273 26.1k

Countries citing papers authored by Xing‐Jie Liang

Since Specialization
Citations

This map shows the geographic impact of Xing‐Jie Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xing‐Jie Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xing‐Jie Liang more than expected).

Fields of papers citing papers by Xing‐Jie Liang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xing‐Jie Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xing‐Jie Liang. The network helps show where Xing‐Jie Liang may publish in the future.

Co-authorship network of co-authors of Xing‐Jie Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Xing‐Jie Liang. A scholar is included among the top collaborators of Xing‐Jie Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xing‐Jie Liang. Xing‐Jie Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Y. Andrew, Kang Wang, Yilin Liu, et al.. (2025). A Spatiotemporally Controllable DNA Hydrogel Mesh for Focused Antimetastasis Therapy of Cancer. ACS Nano. 19(34). 31183–31200.
2.
Zhang, Juncai, Jinchao Zhang, Jinchao Zhang, et al.. (2025). Biomimetic Nanodrug Prepared by Cell Exocytosis Induces Cancer Stem Cell Differentiation by Attenuating Wnt Signaling Pathway. Advanced Healthcare Materials. 14(25). e2500778–e2500778. 1 indexed citations
3.
Zhang, Zhen, Xu Chen, Ningqiang Gong, et al.. (2025). An antigen-capturing and lymph node-targeting nanoparticle for cancer immunotherapy. Journal of Controlled Release. 379. 993–1005. 5 indexed citations
4.
Yao, Yuying, Dongyue He, Haoting Chen, et al.. (2024). Circulating monocyte differentiation-activated nanoprodrugs for reprogramming macrophage immunity in atherosclerotic plaques. Nano Today. 56. 102304–102304. 4 indexed citations
5.
Liang, Xing‐Jie, et al.. (2024). The development of paliperidone nanocrystals for the treatment of schizophrenia. PubMed. 7(1). 12002–12002. 4 indexed citations
6.
Zhong, Haiping, Jingqing Mu, Na Yu, et al.. (2023). Drug content on anticancer efficacy of self-assembling ketal-linked dextran-paclitaxel conjugates. Journal of Controlled Release. 359. 175–187. 14 indexed citations
7.
Zeng, Xiaolong, Yufei Wang, Yun‐Shuai Huang, et al.. (2022). Amphiphilic Metallodrug Assemblies with Red‐Light‐Enhanced Cellular Internalization and Tumor Penetration for Anticancer Phototherapy. Small. 18(52). e2205461–e2205461. 26 indexed citations
8.
Zhang, Kun, Sitong Chen, Jie Chen, et al.. (2022). Physical & Chemical Microwave Ablation (MWA) Enabled by Nonionic MWA Nanosensitizers Repress Incomplete MWA-Arised Liver Tumor Recurrence. ACS Nano. 16(4). 5704–5718. 46 indexed citations
9.
Hu, Bo, Kun Li, Yuanyuan Liu, et al.. (2022). Thermostable ionizable lipid-like nanoparticle (iLAND) for RNAi treatment of hyperlipidemia. Science Advances. 8(7). eabm1418–eabm1418. 76 indexed citations
10.
Huang, Yuanyu, Shuquan Zheng, Xavier de Mollerat du Jeu, et al.. (2022). Ionizable liposomal siRNA therapeutics enables potent and persistent treatment of Hepatitis B. Signal Transduction and Targeted Therapy. 7(1). 38–38. 37 indexed citations
11.
Lu, Mei, Haonan Xing, Tian Zhang, et al.. (2022). Photoactivatable Silencing Extracellular Vesicle (PASEV) Sensitizes Cancer Immunotherapy. Advanced Materials. 34(35). e2204765–e2204765. 68 indexed citations
12.
Chen, Jing, Xue Wang, Yuan Yuan, et al.. (2021). Exploiting the acquired vulnerability of cisplatin-resistant tumors with a hypoxia-amplifying DNA repair–inhibiting (HYDRI) nanomedicine. Science Advances. 7(13). 72 indexed citations
13.
Yang, Lijun, Congrou Zhang, Jinjian Liu, et al.. (2020). ICG‐Conjugated and 125I‐Labeled Polymeric Micelles with High Biosafety for Multimodality Imaging‐Guided Photothermal Therapy of Tumors. Advanced Healthcare Materials. 9(5). e1901616–e1901616. 65 indexed citations
14.
Li, Xiaozhen, Lu Liu, Shengliang Li, et al.. (2019). Biodegradable π-Conjugated Oligomer Nanoparticles with High Photothermal Conversion Efficiency for Cancer Theranostics. ACS Nano. 13(11). 12901–12911. 230 indexed citations
15.
Guo, Weisheng, Jing Chen, Jing Chen, et al.. (2018). Laser-Induced Transformable BiS@HSA/DTX Multiple Nanorods for Photoacoustic/Computed Tomography Dual-Modal Imaging Guided Photothermal/Chemo Combinatorial Anticancer Therapy. ACS Applied Materials & Interfaces. 10(48). 41167–41177. 20 indexed citations
16.
Li, Xianlei, Massimo Bottini, Shuai Zhang, et al.. (2018). Core–Satellite Nanomedicines for in Vivo Real-Time Monitoring of Enzyme-Activatable Drug Release by Fluorescence and Photoacoustic Dual-Modal Imaging. ACS Nano. 13(1). 176–186. 73 indexed citations
17.
Xue, Weiming, Xiaoli Liu, He‐Ping Ma, et al.. (2018). AMF responsive DOX-loaded magnetic microspheres: transmembrane drug release mechanism and multimodality postsurgical treatment of breast cancer. Journal of Materials Chemistry B. 6(15). 2289–2303. 69 indexed citations
18.
Xia, Yang, Jianfei Sun, Liang Zhao, et al.. (2018). Magnetic field and nano-scaffolds with stem cells to enhance bone regeneration. Biomaterials. 183. 151–170. 242 indexed citations
19.
Huo, Shuaidong, Huili Ma, Keyang Huang, et al.. (2012). Superior Penetration and Retention Behavior of 50 nm Gold Nanoparticles in Tumors. Cancer Research. 73(1). 319–330. 288 indexed citations
20.
Wan, Lixin, Xing‐Jie Liang, & Youguo Huang. (2009). Characterization of the ATPase activity of a novel chimeric fusion protein consisting of the two nucleotide binding domains of MRP1. Archives of Biochemistry and Biophysics. 485(2). 102–108. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gang Liu Breakdown of academic impact, for papers by Yaping Li Breakdown of academic impact, for papers by Weibo Cai Breakdown of academic impact, for papers by Samir Mitragotri Breakdown of academic impact, for papers by Ick Chan Kwon Breakdown of academic impact, for papers by Kwangmeyung Kim Breakdown of academic impact, for papers by Morteza Mahmoudi Breakdown of academic impact, for papers by Xian‐Zheng Zhang Breakdown of academic impact, for papers by Xiangliang Yang Breakdown of academic impact, for papers by Wei Tao
Rankless by CCL
2026